SEAL ANALYTICAL LIMITED

Company Registration Number:
04008521 (England and Wales)

Unaudited abridged accounts for the year ended 30 November 2024

Period of accounts

Start date: 01 December 2023

End date: 30 November 2024

SEAL ANALYTICAL LIMITED

Contents of the Financial Statements

for the Period Ended 30 November 2024

Balance sheet
Notes

SEAL ANALYTICAL LIMITED

Balance sheet

As at 30 November 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 284,000 291,000
Tangible assets: 4 0 9,000
Investments: 5 2,208,000 2,208,000
Total fixed assets: 2,492,000 2,508,000
Current assets
Stocks: 53,000 54,000
Debtors:   132,000 98,000
Cash at bank and in hand: 428,000 422,000
Total current assets: 613,000 574,000
Creditors: amounts falling due within one year:   (230,000) (223,000)
Net current assets (liabilities): 383,000 351,000
Total assets less current liabilities: 2,875,000 2,859,000
Total net assets (liabilities): 2,875,000 2,859,000
Capital and reserves
Called up share capital: 230,000 230,000
Share premium account: 575,000 575,000
Profit and loss account: 2,070,000 2,054,000
Shareholders funds: 2,875,000 2,859,000

The notes form part of these financial statements

SEAL ANALYTICAL LIMITED

Balance sheet statements

For the year ending 30 November 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 21 August 2025
and signed on behalf of the board by:

Name: James Mills
Status: Director

The notes form part of these financial statements

SEAL ANALYTICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

Turnover policy

Revenue is measured as the fair value of the consideration received or receivable for goods and services supplied to customers, after deducting sales discounts and value-added taxes, based on the consideration specified in the contract. Revenue is recognised at a point in time for standard revenue transactions when control of the goods provided is transferred to the customer according to the International Commercial Terms of each contract. Separate provision is made for returns and in the few instances where rebates are provided. Under IFRS 15 – Revenue from Contracts with Customers, each customer contract is assessed to identify the performance obligations and for certain service and maintenance contracts, revenue is recognised in relation to these performance obligations as the services are performed in line with the contractual terms. An assessment of the timing of revenue recognition is made for each performance obligation.

Tangible fixed assets and depreciation policy

Tangible fixed assets are stated at historic purchase cost less accumulated depreciation. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use. Depreciation is calculated so as to write down the cost the tangible fixed assets, less estimated residual value, over their estimated economic lives on a straight line basis. Depreciation rates are as follows: Plant, machinery and equipment 25-33% Motor vehicles 25%

Intangible fixed assets and amortisation policy

Software, know-how and design costs are classified as intangible assets and measured initially at purchase cost. Amortisation is charged on a straight line basis over their estimated useful lives, which are deemed to be between 3 and 10 years. Expenditure on research activities is recognised as an expense in the period in which it is incurred. An internally generated intangible asset arising from the Company’s product development expenditure is recognised only if all of the following criteria are demonstrable: The technical feasibility of completing the intangible asset so that it will be available for use or sale; The intention to complete the intangible asset and use or sell it; The ability to use the intangible asset or to sell it; The way in which the intangible asset will generate probable future economic benefits; The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and The ability to measure reliably the expenditure attributable to the intangible asset during its development. Where no internally generated intangible asset can be recognised, development expenditure is recognised as an expense in the period in which it is incurred. All expenditure on the registration, renewal and maintenance of patents and trademarks is written off to the income statement as incurred.

Valuation and information policy

Stocks are stated at the lower of cost and net realisable value. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. Cost is calculated using the weighted average method. Net realisable value represents the estimated selling price less all estimated costs of completion and costs to be incurred in marketing, selling and distribution. Where necessary, provision is made for obsolete, slow moving and defective stocks.

Other accounting policies

Investments Investments are stated at cost less provision for permanent diminution in value.

SEAL ANALYTICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

2. Employees

2024 2023
Average number of employees during the period 6 5

SEAL ANALYTICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

3. Intangible Assets

Total
Cost £
At 01 December 2023 463,000
Disposals (24,000)
At 30 November 2024 439,000
Amortisation
At 01 December 2023 172,000
Charge for year 7,000
On disposals (24,000)
At 30 November 2024 155,000
Net book value
At 30 November 2024 284,000
At 30 November 2023 291,000

SEAL ANALYTICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

4. Tangible Assets

Total
Cost £
At 01 December 2023 55,000
Disposals (54,000)
At 30 November 2024 1,000
Depreciation
At 01 December 2023 46,000
Charge for year 2,000
On disposals (47,000)
At 30 November 2024 1,000
Net book value
At 30 November 2024 0
At 30 November 2023 9,000

SEAL ANALYTICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

5. Fixed investments

Shares in group undertakings Cost at 30 November 2023 and 30 November 2024 £2,703,000 Provision for impairment at at 30 November 2023 and 30 November 2024 £495,000 Net book value at 30 November 2023 and 30 November 2024 £2,208,000 The Directors have considered the carrying value of investments and have concluded that it is supported by their underlying net assets. For the year ended 30 November 2024, there was no impairment of the investments and as at 30 November 2024 no further payments are due to be paid. The Company has the following subsidiary undertakings: Pulse Instrumentation GmbH - Sale of water analysis consumables - Germany - 100% ordinary shares held and voting rights. Rohasys B.V. - Manufacture and sale of robotic sample handling systems - Netherlands - 100% ordinary shares held and voting rights. Seal Analytical GmbH - Manufacture and sale of water analysis equipment and related consumables - Germany - 100% ordinary shares held and voting rights.

SEAL ANALYTICAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

6. Related party transactions

The Company has taken advantage of the exemption in FRS 101 - Reduced Disclosure Framework not to disclose transactions with wholly owned subsidiaries of the Porvair plc group.